Journals / Journal of Neurological Sciences (Turkish) / 2011 / Cilt: 28 - Sayı: 3

Sistemik Lupus Eritematozuslu Bir Olguda Anti-aquaporin-4 Antikor Pozitifliği ile Seyreden Relapsing Nöromiyelitis Optika

Anti-aquaporin-4 Antibody Positive Relapsing Neuromyelitis Optica in a Patient With Systemic Lupus Erythematosus

Pages
376–379
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our casehighlights the importance of testing for the anti-aquaporin-4 autoantibody in the case ofrelapsing myelitis or optic neuritis in patients with SLE for making correct diagnosis andchoosing the appropriate management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neuromyelitis optica (NMO) is a rare inflammatory disorder of the central nervous systemcharacterized by optic neuritis and myelitis.
📊
Key Findings & Data:The patient was seropositive for anti- aquaporin-4 autoantibody, a highly sensitive and specific marker for NMO.
💡
Conclusion & Impact:Our casehighlights the importance of testing for the anti-aquaporin-4 autoantibody in the case ofrelapsing myelitis or optic neuritis in patients with SLE for making correct diagnosis andchoosing the appropriate management.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neuromyelitis optica (NMO) is a rare inflammatory disorder of the central nervous systemcharacterized by optic neuritis and myelitis. NMO may rarely be accompanied by systemicautoimmune disease including systemic lupus erythematosus (SLE). This immunologicaloverlap may reflect the predisposition of patients with NMO to systemic autoimmunity. Wereport a young female with relapsing NMO and SLE. The patient was seropositive for anti- aquaporin-4 autoantibody, a highly sensitive and specific marker for NMO. Our casehighlights the importance of testing for the anti-aquaporin-4 autoantibody in the case ofrelapsing myelitis or optic neuritis in patients with SLE for making correct diagnosis andchoosing the appropriate management.

Özet

Nöromiyelitis optika (NMO) santral sinir sisteminin optik nörit ve miyelit ile karakterizenadir bir inflamatuar bozukluğudur. NMO'ya ender olarak sistemik lupus eritematozusun(SLE) da aralarında bulunduğu sistemik hastalıklar eşlik edebilir. Bu immünolojik birliktelikNMO hastalarının sistemik otoimmüniteye yatkınlığını yansıtabilir. Relapslarla seyredenNMO ve SLE'li bir olgu sunulmaktadır. Hasta NMO için yüksek derecede sensitif ve spesifikolan anti-aquaporin-4 otoantikoru için seropozitifti. Olgumuz, SLE'li bir hastada relapslarlaseyreden miyelit veya optik nörit tablosunda anti-aquaporin-4 otoantikoru tayininin, doğrutanı konması ve uygun tedavinin seçilmesindeki önemini vurgulamaktadır.

🔖

Cite This Article

KAYIM, Ö. Y., BALABAN, H., ŞENEL, S. (2022). Sistemik Lupus Eritematozuslu Bir Olguda Anti-aquaporin-4 Antikor Pozitifliği ile Seyreden Relapsing Nöromiyelitis Optika. Journal of Neurological Sciences (Turkish), Cilt: 28 - Sayı: 3, 376–379. https://ajindex.com/articles/565332

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Birnbaum J, Kerr D. Devic's syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing f or the neuromyelitis optica IgG autoantibody. Arthritis Rheum 2007;57:347-51
  2. Hochberg MC. Updating the American College of Rheumatology revised criteria f or the classif ication of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725
  3. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction f rom multiple sclerosis. Lancet. 2004;364:2106-12
  4. Lucchinetti CF, Mandler RN, McGavern D, et al. A role of humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125:1450- 61
  5. Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non organ-specif ic autoimmunity. Arch Neurol 2008;65:78-83
  6. Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010;17:1019- 32
  7. Sergio P, Mariana B, Alberto O, et al. Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature. Clin Rheumatol. 2010;29:1335-8
  8. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist. 2007;13:2-11
  9. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53:1107-14
  10. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria f or neuromyelitis optica. Neurology 2006;66:1485-9
  11. Akman-Demir G, Tüzün E, Waters P, et al. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. Neurol. 2010 Oct 17. [Epub ahead of print] 12. Marignier R, Giraudon P, Vukusic S, et al. Anti- aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications. Ther Adv Neurol Disord. 2010;3:311-21
  12. Birnbaum J, Petri M, Thompson R, et al. Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum. 2009;60:3378-87
  13. Lepur D, Peterkoviæ V, Kalabriæ-Lepur N. Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis. Neurol Sci. 2009;30:51-4.